Tourmaline Bio, Inc. - Filer Information

Symbol
TRML on Nasdaq
Entity
Company
CIK
0001827506
Business address
27 West 24 Th Street, Suite 702, 10010 New York, NY
Phone
646-481-9832
State of incorporation
DE
Fiscal year end
December 31
Category

Emerging growth company
Former names
Talaris Therapeutics, Inc. (to 10/18/2023)
All SEC filings
View on sec.gov
Get insider transactions for this issuer
Get financial reports for this company